Climb Bio, Inc.

CLYM · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$12,888-$8,666-$20,781-$8,416
Dep. & Amort.$29$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$3,976$1,013$2,022$1,658
Change in WC-$2,788-$3,011$3,931$1,672
Other Non-Cash-$468-$484-$606-$435
Operating Cash Flow-$12,139-$11,148-$15,434-$5,521
Investing Activities
PP&E Inv.-$109$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$23,712-$20,619-$58,751-$60,408
Inv. Sales/Matur.$39,081$25,482$16,000$6,999
Other Inv. Act.$0-$77$0$0
Investing Cash Flow$15,260$4,786-$42,751-$53,409
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$41
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$41
Forex Effect$0$24-$24-$57
Net Chg. in Cash$3,121-$6,338-$58,209-$58,946
Supplemental Information
Beg. Cash$22,682$29,020$87,229$146,175
End Cash$25,803$22,682$29,020$87,229
Free Cash Flow-$12,248-$11,225-$15,434-$5,521